Search results
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoBioNTech (NASDAQ:BNTX) has had a rough three months with its share price down 28%. However, a closer...
BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside.
Investor's Business Daily· 7 months agoCovid vaccine maker BioNTech reported a surprise profit and better-than-expected September-quarter...
BioNTech SE (NASDAQ:BNTX) stock most popular amongst private equity firms who own 44%, while...
Simply Wall St. via Yahoo Finance· 1 year agoA look at the shareholders of BioNTech SE (NASDAQ:BNTX) can tell us which group is most powerful....
Is BioNTech SE's (NASDAQ:BNTX) Latest Stock Performance A Reflection Of Its Financial Health?
Simply Wall St. via Yahoo Finance· 2 years agoMost readers would already be aware that BioNTech's (NASDAQ:BNTX) stock increased significantly by...
BioNTech SE Sponsored ADR (BNTX) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoBioNTech SE Sponsored ADR (BNTX) closed at $124.57 in the latest trading session, marking a +1.63%...
Do Options Traders Know Something About BioNTech (BNTX) Stock We Don't?
Zacks via Yahoo Finance· 2 years agoInvestors in BioNTech SE BNTX need to pay close attention to the stock based on moves in the options...
We Ran A Stock Scan For Earnings Growth And BioNTech (NASDAQ:BNTX) Passed With Ease
Simply Wall St. via Yahoo Finance· 1 year agoFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a...
Is BioNTech (BNTX) a Great Value Stock Right Now?
Zacks via Yahoo Finance· 2 years agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks....
BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics
Zacks via Yahoo Finance· 2 years agoBioNTech (BNTX) signs a research collaboration agreement with Ryvu Therapeutics to develop small...
BioNTech Dives As Pfizer Partner Reports Lagging Covid Vaccine Sales, Guidance
Investor's Business Daily· 2 years agoGerman Covid vaccine developer BioNTech lagged second-quarter estimates and reiterated disappointing...